Peritoneal Surface Malignancies
PRIYA KAPOOR, DrNB Sugrical Oncology
Consultant
Apollo Cancer Center
Chennai, Tamil Nadu, India
PRIYA KAPOOR, DrNB Sugrical Oncology
Consultant
Apollo Cancer Center
Chennai, Tamil Nadu, India
PRIYA KAPOOR, DrNB Sugrical Oncology
Consultant
Apollo Cancer Center
Chennai, Tamil Nadu, India
Venkat P, Mch Surgical Oncology
Consultant
Apollo Cancer Centre, Tamil Nadu, India
Vimalathithan NS, n/a
Consultant
Apollo Cancer Centre, United States
Magesh M, n/a
Associate Consultant
Apollo Cancer Centre, United States
Ezhil P, n/a
Resident Surgical Oncology
Apollo Cancer Centre, United States
Cytoreductive surgery with or without HIPEC has been associated with high morbidity . Now with the procedure being exceedingly done it is important to work towards making it safe and focus on early recovery . Moreover the safety and early recovery helps the patients to start adjuvant treatment faster with better tolerability . ERAS has shown to dramatically improve post operative outcomes in many procedures .
It has been extensively studied and followed for other procedures but not for these cases .
We examined the safety and feasibility of the ERAS protocol implementation for patients undergoing CRS/HIPEC .
Methods: All patients with peritoneal carcinomatosis who underwent CRS with or without HIPEC between July 2021 to august 2022 were identified . Patient characteristics , disease pathology and peri operative details were matched . Primary outcomes were length of hospital stay , ICU stay , 30-day readmission , compliance , renal dysfunction , complications
Results: A total of 57 patients were included who underwent CRS/HIPEC with ERAS implementation . The compliance was 83 % . There was significant decrease in the length of stay with ERAS pathway from 9 days to 6 days (P=0.002). There was no increase in 30 d readmissions . None of the patients had alteration in kidney profile . There was significant decrease in morbidity rates with significant decrease in paralytic ileus and SSIs
Conclusions: – ERAS pathway implemention is feasible with significant decrease of length of hospital stay without evidence of increased complications or readmissions .Eras protocols should be an important part of CRS/HIPEC procedures